Filter
363
Filtered Results: 363
Text search:
pfizer
Featured
Recommendations
44
New Publications
18
Language
Document type
No document type
89
Guidelines
82
Studies & Reports
78
Fact sheets
43
Manuals
20
Strategic & Response Plan
20
Resource Platforms
10
Situation Updates
5
Infographics
5
Training Material
4
Videos
4
Online Courses
3
Countries / Regions
Brazil
18
Russia
13
Global
12
South Africa
10
Argentina
10
Germany
9
Ukraine
8
Middle East and North Africa
7
Latin America and the Carribbean
7
Mozambique
6
Africa
6
India
5
Chile
5
Ecuador
4
West and Central Africa
4
Western and Central Europe
4
Senegal
3
China
3
Colombia
3
East and Southern Africa
3
Paraguay
3
Liberia
2
Nigeria
2
Uganda
2
Philippines
2
Kenya
2
Indonesia
2
Peru
2
El Salvador
2
Eastern Europe
2
Sierra Leone
1
Congo, Democratic Republic of
1
Guinea-Bissau
1
Ghana
1
Somalia
1
Nepal
1
South Sudan
1
Iraq
1
Lebanon
1
Syria
1
Chad
1
Tanzania
1
Sudan
1
Benin
1
Angola
1
Yemen
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Congo-Brazzaville
1
Timor Leste/ East Timor
1
Iran
1
Kazakhstan
1
United Kingdom
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
120
Clinical Guidelines
26
Public Health
9
Women & Child Health
7
Key Resources
4
Pharmacy & Technologies
2
Annual Report MEDBOX
1
Toolboxes
COVID-19
184
Mental Health
35
TB
17
HIV
15
NTDs
14
AMR
12
NCDs
9
Refugee
8
Rapid Response
7
Global Health Education
6
Health Financing Toolbox
5
Disability
4
Ebola
3
Caregiver
3
Pharmacy
3
Conflict
2
Zika
1
Planetary Health
1
Vaccination programmes against COVID-19 and seasonal influenza are currently being implemented in parallel in many countries. Administration of both vaccines during the same visit has potential advantages. This document presents the evidence related to coadministration of Covid-19 and influenza vacc...
CEPI is seeking to raise $3.5 billion to implement CEPI’s next 5-year plan. To mitigate the immediate threat of COVID-19 variants, it is activating key elements of this plan now—and seeking to mobilise a portion of this $3.5 billion in 2021. We have already launched R&D programmes to initiate de...
Abbreviated Report of a WHO Consultation
Evidence for technical update of pocket book recommendations. Newborn conditions, dysentery, pneumonia, oxygen use and delivery, common causes of fever, severe acute malnutrition and supportive care
Recommendations for a public health approach
2010 revision
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s...
WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses
Situation Analaysis and Needs Assessment
WHO Guideline. Since 2010, countries in the meningitis belt have started to introduce a new serogroup A meningococcal conjugate vaccine conferring individual protection and herd immunity. Following the successful roll-out of this vaccine, epidemics due to Neisseria meningitidis serogroup A (NmA) are...
PLOS Neglected Tropical Diseases September 2014 | Volume 8 | Issue 9 | e3016 DOI: 10.1371/journal.pntd.0003016
This guideline provides health policy-makers and decision-makers in health professional training institutions with advice on the rationale for health-care providers’ use of counselling skills to address sexual health concerns in a primary health care setting
Irresponsible pharmaceutical companies fuel the proliferation of superbugs through supply chain pollution, the European Public Health Alliance (EPHA) reports. The advocacy group uncovered lapses such as dirty production and inadequate waste disposal in the production of antimicrobials in China and I...
Prices people pay for medicines.
These WHO guidelines which were updated in 2018, are valid for any country and suitable to local adaptations, and take account of the strength of available scientific evidence, the cost and resource implications, and patient values and preferences.
The 2018 edition of the guidelines includes the re...
